by Miami Stem Cell | May 26, 2021 | Macular Degeneration, regenerative medicine, stem cell therapy
Researchers at the National Eye Institute (NEI) are launching a clinical trial to test the safety of a novel patient-specific stem cell-based therapy to treat geographic atrophy, the advanced “dry” form of age-related macular degeneration (AMD), a leading cause of...
